Cite
HARVARD Citation
Arndtz, K. et al. (2017). Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol. BMJ open. 7 (6), p. . [Online].